ConductScience.org, home

Paper6170971

Hormonal and blood pressure changes during converting enzyme inhibition by teprotide.

VandenBurg MJ and 4 others. Postgrad Med J, 1981. Cited by 0 papers, by iCite.

Cite this record

ConductScience Library. Hormonal and blood pressure changes during converting enzyme inhibition by teprotide. Papers, record 6170971. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/6170971

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Hormonal and blood pressure changes during converting enzyme inhibition by teprotide.
PubMed
Journal
Postgrad Med J
PubMed
Year
1981
PubMed
Publication types
Case Reports, Journal Article
PubMed
Citations, by iCite
0
iCite
Relative citation ratio, by iCite
0
iCite
Revised in PubMed
2019-05-01
PubMed

Authors5

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1VandenBurg MJM J
2Sharman VLV L
3Morton JJJ J
4Williams GHG H
5Marsh FPF P

Source PubMed

Download CSV of authors

Topics13

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Angiotensin-Converting Enzyme InhibitorsMajor topic
Hypertension, RenalMajor topic
OligopeptidesMajor topic
ReninMajor topic
TeprotideMajor topic
Aldosterone
Angiotensin I
Angiotensin II
Bradykinin
Female
Humans
Kidney Transplantation
Radioimmunoassay

Source PubMed

Download CSV of topics

References16

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
15350207A radioimmunoassay for bradykinin in plasma and synovial fluid.J Lab Clin Med1969https://conductscience.org/library/papers/5350207PubMed
2233366Converting enzyme inhibition in essential hypertension: the hypotensive response does not reflect only reduced angiotensin II formation.Hypertension1979https://conductscience.org/library/papers/233366PubMed
34785142A comparison of double-isotope derivative and radioimmunological estimation of plasma aldosterone concentration in man.Clin Sci Mol Med1973https://conductscience.org/library/papers/4785142PubMed
4234806Angiotensin I converting enzyme.Circ Res1975https://conductscience.org/library/papers/234806PubMed
5235218Inhibition of angiotensin conversion and prevention of renal hypertension.Am J Physiol1975https://conductscience.org/library/papers/235218PubMed
6167999Disappearance of bradykinin in the renal circulation of dogs. Effects of kininase inhibition.Circ Res1975https://conductscience.org/library/papers/167999PubMed
7174834The role of the renin-angiotensin-aldosterone system in cardiovascular homeostasis in normal human subjects.Circulation1976https://conductscience.org/library/papers/174834PubMed
8830432The cost of scientific communication: the scientist as ad-man.Circ Res1977https://conductscience.org/library/papers/830432PubMed
9195203Accentuated vascular and endocrine response to SQ 20881 in hypertension.N Engl J Med1977https://conductscience.org/library/papers/195203PubMed
10639180Converting enzyme inhibitor and saralasin infusion in rats. Evidence for an additional vasodepressor property of converting enzyme inhibitor.Circ Res1978https://conductscience.org/library/papers/639180PubMed
11709099Prolonged treatment of high-renin hypertension with a converting enzyme inhibitor.Br Med J1978https://conductscience.org/library/papers/709099PubMed
1290216Long-term effects of captopril (SQ14 225) on blood-pressure and hormone levels in essential hypertension.Lancet1979https://conductscience.org/library/papers/90216PubMed
136986949Effects of an angiotensin-converting enzyme inhibitor (captopril) on blood pressure in anephric subjects.Br Med J1980https://conductscience.org/library/papers/6986949PubMed
14232086The effect of converting enzyme inhibition with SQ20,881 on plasma and urinary kinins, prostaglandin E, and angiotensin II in hypertensive man.Hypertension1979https://conductscience.org/library/papers/232086PubMed
156992919Absence of blood-pressure lowering effect of captopril in anephric patients.Br Med J1980https://conductscience.org/library/papers/6992919PubMed
164327809Characterization of a dipeptide hydrolase (kininase II: angiotensin I converting enzyme).J Pharmacol Exp Ther1971https://conductscience.org/library/papers/4327809PubMed

Download CSV of references

Genes3

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
AGT183PubTator's text mininghttps://conductscience.org/library/genes/183NCBI Gene
KNG13827PubTator's text mininghttps://conductscience.org/library/genes/3827NCBI Gene
REN5972PubTator's text mininghttps://conductscience.org/library/genes/5972NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Cited by
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/6170971

GET https://conductscience.org/api/papers/v1/6170971/authors